UnitedHealth Group (UNH) to Release Quarterly Earnings on Tuesday

UnitedHealth Group (NYSE:UNH) is set to announce its earnings results before the market opens on Tuesday, October 15th. Analysts expect the company to announce earnings of $7.05 per share for the quarter. UnitedHealth Group has set its FY 2024 guidance at 27.500-28.000 EPS and its FY24 guidance at $27.50-28.00 EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the firm earned $6.14 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, analysts expect UnitedHealth Group to post $28 EPS for the current fiscal year and $31 EPS for the next fiscal year.

UnitedHealth Group Trading Up 0.1 %

Shares of NYSE UNH opened at $598.05 on Friday. The stock has a market capitalization of $552.25 billion, a PE ratio of 39.66, a PEG ratio of 1.66 and a beta of 0.58. The stock has a fifty day simple moving average of $583.64 and a 200-day simple moving average of $531.08. UnitedHealth Group has a twelve month low of $436.38 and a twelve month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 55.70%.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on UNH shares. Morgan Stanley lifted their target price on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Tuesday, October 1st. Barclays boosted their target price on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their target price for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. Finally, Argus boosted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $617.37.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.